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Abstract To study seasonal inter-individual and intra-in-
dividual variations in serum 25-hydroxy vitamin D
(25(OH)D) and to explore parameters associated with
25(OH)D in a healthy Swedish adult population. 540 blood
donors (60 % men; mean age 41 ± 13 years) and 75 throm-
bocyte donors (92 % men, aged 46 ± 11 years) were in-
cluded. Serum was collected during 12 months and analyzed
for 25(OH)D and parathyroid hormone (S-iPTH). The blood
donors answered questionnaires concerning vitamin D sup-
plements, smoking, physical activity, sunbed use and sun
holidays. Repeated serum samples were collected from the
thrombocyte donors to study the intra-individual variations in
S-25(OH)D. S-25(OH)D varied greatly over the year corre-
lating with the intensity of the UV-B irradiation (rS = 0.326;
p\ 0.001). During January–March, a S-25(OH)D level
below the thresholds of 50 and 75 nmol/L was observed in 58
and 88 %, respectively, and during July–September in 11 and
50 % (p\ 0.001). S-25(OH)D was negatively correlated with
body mass index and S-iPTH, but was significantly higher in
holiday makers in sunny destinations, sunbed users, non-
smokers, and in the physically active. The intra-individual
analyses showed a mean increase in S-25(OH)D by 8 nmol/
L/month between April and August. Approximately 75 % had
serum 25(OH)D values\75 nmol/L during 75 % of the year
and 50 % had serum 25(OH)D\50 nmol/L during 50 % of
the year. Serum 25(OH)D was strongly associated with pa-
rameters related to sun exposure, but only weakly with intake
of vitamin D supplements.
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Introduction
Vitamin D is essential for the skeletal metabolism, muscle
function, calcium homeostasis, and the immune system. In
recent years, a growing body of observational data has
demonstrated an association between poor vitamin D status
and chronic illness, including autoimmune diseases, cancer,
infections, diabetes, liver disease, and cardiovascular disease
[1–9]. Vitamin D3 is a prohormone that undergoes successive
hydroxylation in the liver (25-hydroxy vitamin D; 25(OH)D)
and the kidneys (1, 25-hydroxy vitamin D; 1,25 (OH)2D).
25(OH)D is the principal form of circulating vitamin D and the
metabolite which best reflects the vitamin D status [10].
Vitamin D can either be endogenously produced in the
skin through the photolysis of 7-dehydocholesterol to
precholecalciferol (previtamin D3) by ultraviolet radiation,
or orally ingested through vitamin D-rich nutrients, such as
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fatty fish, egg yolk, certain mushrooms, or meat. However,
at northern latitudes, the ultraviolet irradiance is too low to
allow the photolysis of vitamin D during the winter months
and the populations are dependent on the vitamin D con-
sumed through food or supplements [11–13].
Osteomalacia occurs at low levels of 25(OH)D, usually
below 25 nmol/L, but there is currently no consensus on
the optimum levels of vitamin D. A serum 25(OH)D level
below 50 nmol/L is considered inadequate, based on inte-
gration of bone health outcomes [14]. Adequate vitamin D
status (‘‘vitamin D sufficiency’’) can also be defined as the
level where the serum parathyroid hormone (PTH) is stable
and does not decrease further with vitamin D supplemen-
tation, which corresponds to a serum level of 25(OH)D of
around 75 nmol/L [15–17].
Low levels of 25(OH)D have been observed in sig-
nificant proportions of the populations around the world
and is very common among the institutionalized elderly
population [15, 18–22].
The seasonal changes in vitamin D status in the healthy
adult population in Sweden have not been fully evaluated.
Furthermore, the proportion of the population that would
need vitamin D supplementation to reach the target of a
serum 25(OH)D level of 50 and 75 nmol/L, respectively, is
not known. In addition, knowledge about the mean indi-
vidual changes in vitamin D status over the year would
allow us to predict the vitamin D status at different times of
the year from a single vitamin D measurement.
The aims of the present study were, (a) to analyze the
serum concentrations of 25(OH)D in healthy adult indi-
viduals during different seasons of the year; (b) to study
demographic and lifestyle-related parameters associated
with serum 25(OH)D; and (c) to investigate the intra-in-
dividual variation in serum 25(OH)D over time and during
different seasons of the year.
Materials and methods
Study population
Healthy blood donors resident in Gothenburg, Sweden
(57410N, 11590E), were invited to participate in the study
when giving blood. A total of 540 blood donors were in-
cluded consecutively, 40–60 in the middle of each month
from October 2009 to September 2010.
The blood donors all stated that they were in full health
and answered questionnaires regarding medication, in-
cluding vitamins and complementary alternative medica-
tion, smoking habits, physical activity, use of a vegetarian
diet, sunbed use, and if they had traveled to a sunny
country, defined as a journey to southern latitudes below
43 N, during the month before inclusion. Height and
weight were measured and the body mass index (BMI)
calculated.
To study the inter-individual seasonal variation in serum
25(OH)D, repeated serum samples were collected from
thrombocyte donors during a period from April to
November, 2008. Thrombocyte donors are required to be
healthy and free from medication. Since thrombocytes are
separated from the blood via apheresis, these donors are
allowed to donate thrombocytes every 2 weeks, enabling
collection of multiple samples from the same individual.
Written informed consent was obtained from all par-
ticipants. The study was approved by the local Regional
Ethics Committee in Gothenburg and carried out in ac-
cordance with the Helsinki declaration.
Laboratory analyses
Serum samples were frozen at -80 C immediately after
collection and stored for up to 1 year before analysis. After
thawing, the samples were all analyzed on the same day.
Serum 25(OH)D (both D2 and D3) and serum osteocal-
cin concentrations were analyzed with chemiluminescence
immunoassay (CLIA) on a LIAISON instrument (DiaSorin
Inc, Stillwater, MN, USA).
The total coefficient of variance (CV) for serum
25(OH)D was 5–6 %, with the highest variance in the
lowest test range, and the functional sensitivity was
12.5 nmol/L at a CV of 8 %.
The total CV for serum osteocalcin was 4–6.5 %, with
the highest variance in the lowest test range, and the
functional sensitivity was 3 lg/L at a CV of 17 %.
Serum concentrations of intact parathyroid hormone
(iPTH) were analyzed with CLIA on an Abbott ARCHI-
TECT instrument (Abbott Diagnostics Division, Abbott
Park, IL, USA). The total CV for iPTH ranged from 2.8 to
3.2 %. The functional sensitivity was below 5 ng/L at a CV
of 20 %. The reference interval for iPTH, provided by the
manufacturer, was 15–68 ng/L (percentile 2.5–97.5).
Serum calcium, albumin, and phosphate were analyzed
on a Cobas instrument (Roche Molecular Diagnostics,
Pleasanton, CA, USA).
Ultraviolet radiation
Monthly sums of Commission Internationale de l’E´clairage
(CIE)-weighted UV radiation (Wh/m2), which mimics the
erythemal effect of UV radiation, were calculated for
Gothenburg (57410N, 11590E) for the period October
2009 to September 2010 using the Swedish Meteorological
and Hydrological Institute’s (SMHI) solar radiation model
STRA˚NG (www.strang.smhi.se).
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Statistics
Statistical analyses were performed using the PASW
Statistics 18.0 (SPSS Inc., IBM, Chicago USA). Descrip-
tive statistics are presented as medians and ranges and/or
mean and standard deviations (SD). The T test was used for
comparison of normally distributed variables and the
Mann–Whitney U test for abnormally distributed variables.
The v2 test was used to compare categorical variables.
Correlations were calculated using Spearman’s correlation
(rs). For dichotomous variables, yes was coded as 1 and no
as 0. All tests were two-tailed and p\ 0.05 was considered
statistically significant. Linear regression was run with
serum 25(OH)D as the outcome and the variables sig-
nificantly associated with serum 25(OH)D in the univariate
analyses as covariates (sum of CIE-weighted UV radiation
during sampling month, sex, age, BMI, estrogen use, sunny
holidays, sunbed use, smoking, and physical activity). A
mixed model was used to analyze the data from repeated
measurements.
Results
Demographics of the healthy subjects
A total of 540 blood donors (215 women and 325 men)
with a mean age of 40.5 ± 13.0 years were included in the
study. The characteristics of the blood donors are given in
Table 1.
In addition, a total of 300 blood samples were collected
from 75 thrombocyte donors (6 women and 69 men) with a
mean age of 45.8 ± 10.9 years. Multiple blood samples,
up to 11 from the same individual, were acquired.
Seasonal variations in serum 25(OH)D: blood donors
The CIE-weighted UV radiation increased from 0.36 Wh/
m2 in December to 24.25 Wh/m2 in July and was positively
correlated with serum 25(OH)D (rS = 0.333; p\ 0.001)
Great variations were found in the mean concentrations of
25(OH)D during the different months of the year (Table 2
and Fig. 1). The mean serum concentration of 25(OH)D
was 73 % higher in July (81.9 ± 26.2 nmol/L) than in
February (47.4 ± 20.7 nmol/L), (p\ 0.001). The mean
serum concentration of 25(OH)D during the third quarter of
the year (July to September, 77.7 ± 27.3 nmol/L) was
62 % higher than during the first quarter of the year (Jan-
uary–March, 47.9 ± 19.6 nmol/L), (p\ 0.001).
During the first quarter of the year (January–March),
58.3 % (70/120) had serum concentrations of 25(OH)D
lower than 50 nmol/L, and 87.5 % (105/120) had levels
lower than 75 nmol/L, compared with the third quarter of
the year (July–September), when 11.3 % (18/160) had
levels below 50 nmol/L and 50 % (80/160) had levels
below 75 nmol/L (p\ 0.001) (Table 2 and Fig. 2).
Serum iPTH, osteocalcin, calcium, and phosphate
and the relationship with 25(OH)D
Mean and median concentrations of serum iPTH, osteo-
calcin, calcium, albumin, and phosphate are shown in
Table 1. Serum 25(OH)D was correlated with serum iPTH
(rS = -0.253; p\ 0.001), serum osteocalcin (rS =
-0.087; p = 0.042), and serum phosphate (rS = 0.122;
p = 0.005), but not with serum calcium (rS = -0.058;
p = 0.184) or albumin (rS = -0.058; p = 0.176).
There was a significant difference in serum iPTH
(p\ 0.001), but not in serum osteocalcin, between groups
of subjects with different levels of serum 25(OH)D (\25;
25–49, 50–74; [75 nmol/L). A serum iPTH above the
reference interval of 15–68 ng/L was observed in totally
9.1 % (n = 49) of the blood donors,
The relation between level of serum 25(OH)D and the
percentage of subjects with a serum iPTH above 68 ng/L
was as follows: \25 nmol/L 32 %, 25–49 nmol/L 11 %,
50–74 nmol/L 8 %, and[75 nmol/L 5 %.
Serum iPTH was significantly higher during the first
quarter of the year (January–March) then during the third
quarter (July–September) (S-iPTH 47.2 ± 19.1 vs.
42.4 ± 17.3; p = 0.031), whereas the opposite was ob-
served for serum phosphate (S-phosphate 1.23 ± 0.26 vs.
1.47 ± 0.60; p\ 0.001), which thus was lower during the
first quarter. No significant differences were found in
serum osteocalcin, calcium, or albumin during the different
quarters of the year (Table 2).
iPTH was positively correlated with BMI (rS = 0.193;
p\ 0.001).
Demographic and lifestyle-related parameters
in relation to concentrations of serum 25(OH)D: blood
donors
The associations between serum 25-OHD and demographic
and lifestyle-related parameters are shown in Table 3. The
female study participants had significantly higher serum
25(OH)D levels than the men. Serum 25(OH)D was also
significantly higher in sunbed users, in subjects who had
visited a sunny country during the month before inclusion,
in subjects doing physical exercise regularly every week,
and in non-smokers compared with smokers. Among the
female study subjects, the serum concentrations of
25(OH)D were significantly higher in users of estrogens
(contraceptives or hormone replacement therapy) com-
pared with non-users. Weak negative correlations were
found between serum 25(OH)D and weight (rS = -0.147;
802 Endocrine (2015) 49:800–808
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p = 0.001) and BMI (rS = -0.179; p\ 0.001), but not
with age or height. No significant differences in serum
25(OH)D were found in vegetarians or between users or
non-users of vitamin D supplements, complementary al-
ternative medication, or prescribed medication (mostly
contraceptives, anti-allergy, or asthma medication).
In total, 50 subjects were using vitamin D supplements,
mostly multivitamin preparations with daily doses of vi-
tamin D3 of 5–7.5 lg (200–300 IE). When comparing the
effect of vitamin D supplements during the winter and
summer months, we found significantly higher serum
25(OH)D levels in vitamin D users during the winter
(59.0 ± 21.0 vs. 49.2 ± 19.4 nmol/L, p = 0.015), but not
during the summer.
We also found that physical activity ([once a week) was
associated with higher serum concentrations of 25(OH)D
during the summer (74.9 ± 27.5 vs. 67.2 ± 23.1;
p = 0.026), but not during the winter.
More women than men answered that they had used a
sunbed during the month before inclusion in the study (17/
214 vs. 6/326, p = 0.001). When the sunbed users were
excluded, no significant difference in serum 25(OH)D
could be found between women and men.
In multiple linear regression analyses, serum 25(OH)D was
independently associated with CIE-weighted UV radiation
during the sampling month (B = 1.04; p\0.001), BMI
(B = -1.48; p\0.001), estrogen use (B = 15.43;
p = 0.002), and having traveled to a sunny country (B = 21.76;
p\0.001) or used a sunbed (B = 22.73; p\0.001) during the
month before the inclusion in the study (R2 = 0.269).
Intra-individual variations in serum 25(OH)D
during different seasons of the year: results
from the thrombocyte donors
The mean serum concentrations of 25(OH)D followed the
intensity of the UV light irradiance in the Gothenburg area
and peaked in July, whereafter they decreased. The mean
increase in serum 25(OH)D from April to August was
0.268 nmol/L/day (95 % CI 0.239–0.298 nmol/L/day) or
8.0 nmol/L/month (Fig. 3). The individual minimum and
maximum serum levels of 25(OH)D in the study subjects
were strongly correlated (rS = 0.684; p\ 0.001), indicat-
ing that each individual follows his/her own curve. The
intra-individual maximum change in serum 25(OH)D is
shown in Table 4.
Table 1 Characteristics of the 540 blood donors included in the study




Age (years) 41 (16, 71) 40.5 ± 13.0
Body weight (kg) 76 (36, 183) 77.6 ± 15.2
Body length (cm) 177 (155, 205) 176.6 ± 8.9
Body mass index (kg/m2) 24 (12, 61) 24.8 ± 4.0
Current smokers 25 (4.6)
Subjects who had used a sunbed during the previous month 23 (4.3)
Subjects on a sunny holiday during the previous month 36 (6.7)
Subjects reporting a vegetarian diet 26 (4.8)
Subjects who exercise once a week 150 (27.7)
Subjects taking vitamin D supplements 50 (9.2)
Female study subjects taking estrogens (contraceptives or HRT) 24/215 (11.2)
Subjects on any medication (other than vitamin D) 62 (11.5)
Subjects on complementary and alternative medicine 77 (14.2)
Serum 25(OH)D (nmol/L) 60 (10, 224) 62.8 ± 26.3
Serum iPTH (ng/L) 40 (8.7, 151) 44.0 ± 18.6
Serum osteocalcin (lg/L) 14 (5.7, 39) 15.1 ± 5.4
Serum calcium (mmol/L) 2.38 (1.85, 2.82) 2.39 ± 0.13
Serum albumin (g/L) 42 (31, 50) 41.7 ± 3.1
Serum phosphate (mmol/L) 1.3 (0.7, 4.6) 1.3 ± 0.4
25(OH)D 25-hydroxy vitamin D, iPTH intact parathyroid hormone, HRT hormone replacement therapy
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Discussion
The present study shows that vitamin D insufficiency is
common among Swedish adult healthy women and
men, especially during the winter months. In total, 54 %
(129/240) of the included blood donors had a serum
25(OH)D level lower than 50 nmol/L during December to
May. Using the higher threshold for vitamin D insuffi-
ciency, 75 nmol/L, 75 % were found to be vitamin D in-
sufficient during the three quarters of the year. [17]. This
clearly shows that even though dairy products are supple-
mented with vitamin D in Sweden, the diet fails to provide
an adequate amount of vitamin D during the winter




























Fig. 1 Box plot of serum 25(OH)D during the different months of the
year. The values shown represent medians (horizontal line), in-
terquartile ranges (box), and ranges of values (whiskers)
Fig. 2 Pie-diagram of serum 25(OH)D during different seasons in
relation to recommended levels























Q1 119 47.9 ± 19.6 47.2 ± 19.1 2.37 ± 0.10 1.23 ± 0.26 13 (10.9) 70 (58.8) 105 (88.2)
January 39 48.4 ± 17.4 3 (7.7) 24 (61.5) 36 (92.3)
February 40 47.4 ± 20.7 5 (12.5) 22 (55.0) 34 (85.0)
March 40 48.0 ± 21.0 5 (12.5) 24 (60.0) 35 (87.5)
Q2 140 60.8 ± 24.5 44.2 ± 18.3 2.38 ± 0.10 1.25 ± 0.24 3 (2.1) 51 (36.4) 106 (75.7)
April 40 50.3 ± 20.0 2 (5.0) 22 (55.0) 36 (90.0)
May 40 53.8 ± 17.1 1 (2.5) 19 (47.5) 33 (82.5)
June 60 72.6 ± 26.7 0 (0) 10 (16.7) 37 (61.7)
Q3 160 77.7 ± 27.3 42.4 ± 17.3 2.35 ± 0.13 1.47 ± 0.60 2 (1.3) 18 (11.3) 80 (50.0)
July 60 81.9 ± 26.2 0 (0) 5 (8.3) 27 (45.0)
August 60 80.4 ± 29.8 1 (1.7) 6 (10.0) 26 (43.3)
September 40 67.4 ± 22.7 1 (2.5) 7 (17.5) 27 (67.5)
Q4 121 60.2 ± 22.5 42.8 ± 20.1 2.47 ± 0.14 1.34 ± 0.29 7 (5.8) 36 (29.8) 97 (80.2)
October 40 69.9 ± 24.1 0 (0) 7 (17.5) 26 (65.0)
November 41 56.8 ± 18.3 4 (9.8) 11 (26.8) 37 (90.2)
December 40 54.2 ± 22.2 3 (7.5) 18 (45.0) 34 (85.0)
Allb 540 60.9 ± 22.2 5.1 % 35.1 % 74.6 %
Serum 25-hydroxy vitamin D in relation to recommended levels during different months and quarters of the year in 540 blood donors. Numbers
represent mean ± standard deviation or number (%)
25(OH)D 25-hydroxy vitamin D, iPTH intact parathyroid hormone, Q quarter of the year, SD standard deviation
a Cumulative lists including all subjects with S-25(OH)D below 50 and 75 nmol/L, respectively
b The mean of the monthly mean values. Values are adjusted for the fact that more subjects were included during the summer months
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adult healthy population would need extra vitamin D sup-
plementation during the winter months to reach the target
level of 50 nmol/L.
Our results are in contrast to earlier studies which have
shown a low prevalence of vitamin D deficiency among
Scandinavian (mostly Danish and Norwegian) young adults
and elderly, in comparison with the population in
Mediterranean Europe [23–26]. It has been argued that this
is due to high intake of fatty fish, vitamin-supplemented
dairy products, and vitamin D supplements in Scandinavia.
In an earlier Swedish study on women aged 61–86 years,
only 19 % had a serum 25(OH)D level below 50 nmol/L
during the winter; however, a high percentage, 25 %, of the
participants had been on a sunny holiday during the winter
[27]. Another explanation of the discrepancy could be a
greater awareness of osteoporosis and the need for calcium
and vitamin D intake among postmenopausal women.
Sweden and the Scandinavian countries top the ranking list
of ten-year probabilities of a hip fracture, which can be
used as an indicator of the prevalence of osteoporosis in a
country [28, 29]. The serum levels of 25(OH)D in the


















1 April 1 June 1 August 1 October 1 December
2008
Fig. 3 Intra-individual changes in serum 25(OH)D from April to
August




Women versus men 65.6 ± 25.3 versus 61.0 ± 26.8 0.046
Women versus men (when sunbed users were excluded) 63.8 ± 22.9 versus 60.8 ± 27.0 0.20
Age B 29 versus C51 years (first quartile versus forth quartile) 63.6 ± 30.2 versus 59.7 ± 21.8 0.213
BMI B 22.4 versus C26.8 kg/m2 (first quartile versus forth quartile) 65.5 ± 26.3 versus 54.7 ± 22.2 \0.001
Smokers versus non-smokers 51.4 ± 26.2 versus 63.4 ± 26.2 0.031
Sunbed users versus non-users 82.2 ± 35.6 versus 62.0 ± 25.5 \0.001
Subjects on a sunny holiday during the previous month, yes versus no 86.9 ± 37.7 versus 61.1 ± 24.4 \0.001
Physically activea versus non-active 64.5 ± 26.7 versus 58.4 ± 24.7 0.015
Female study subjects using estrogensb versus non-users 84.0 ± 38.3 versus 63.3 ± 22.2 0.016
Vitamin D supplement users versus non-users (during the whole year) 64.7 ± 19.5 versus 62.7 ± 26.9 0.49
Vitamin D supplement users versus non-users (winter months only) 59.0 ± 21.0 versus 49.2 ± 19.4 0.01
Medication (other than vitamin D), users versus non-users 70.3 ± 34.2 versus 61.9 ± 24.9 0.065
Users of a vegetarian diet versus non-users 59.7 ± 23.1 versus 63.0 ± 26.4 0.53
Complementary and alternative medicine users versus non-users 63.3 ± 21.8 versus 62.8 ± 27.0 0.87
25(OH)D 25-hydroxy vitamin D, BMI body mass index
a Physically active defined as performing physical exercise regularly at least once a week
b estrogens were taken as contraceptives or hormone replacement therapy
Table 4 Intra-individual
maximum change in serum
25(OH)D in relation to target
levels
25(OH)D 25-hydroxy vitamin D
Minimum levels of serum 25(OH)D % (n) Maximum levels of serum 25(OH)D % (n)
25–50 nmol/L 50–75 nmol/L [75 nmol/L
\25 nmol/L 100 % (5) 60 % (3) 20 % (1) 20 % (1)
25–50 nmol/L 100 % (33) 21 % (7) 49 % (16) 30 % (10)
50–75 nmol/L 100 % (27) 0 % (0) 33 % (9) 67 % (18)
[75 nmol/L 100 % (10) 0 % (0) 0 % (0) 100 % (10)
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an earlier study on elderly men living in the Gothenburg
area [22].
Interpreting and taking action on serum 25(OH)D values
analyzed during different seasons of the year may pose a
problem to the clinician. In most cases, the time of the
appointment is not optimally chosen to study the levels of
vitamin D. The results from the current study show that a
value of 25(OH)D measured in late spring can be expected
to be about 35.1 ± 16.3 nmol/L higher in late summer and
vice versa.
The present study shows that the mean levels of serum
calcium among the participants were stable during the
different seasons of the year. The maintenance of the serum
calcium concentration within a narrow range is essential
for physiological processes, a balance which is regulated
by parathyroid hormone and vitamin D. Serum iPTH was
thus significantly higher during the winter months, when
serum 25(OH)D reached its nadir values. Serum phosphate
was however significantly higher during the summer
months, when serum 25(OH)D reached its peak values,
reflecting the positive effects of 1,25 (OH)2D on intestinal
phosphate absorption.
The main source of vitamin D is the endogenous pro-
duction in the skin following sun exposure [30]. In the
present study, a recent visit to a sunny country and sunbed
use were strongly and independently associated with higher
serum 25(OH)D levels, whereas only a weak association
was found between the levels and intake of vitamin D
supplements. The daily doses of vitamin D3 supplements
reported by the participants (5-7.5 lg; 200-300 IU/day)
may, however, have been too low to achieve optimum
levels of vitamin D [31]. In addition, the vitamin D sup-
plements may only have been taken sporadically. Our re-
sults are supported by a recent Swedish study on middle-
aged female primary care patients, which reported a strong
association between sunny holidays and vitamin D status
during the winter, but no association between serum
25(OH)D levels and intake of vitamin D by food or sup-
plements. The prevalence of serum 25(OH)D levels below
50 nmol/L was comparable to our results, 50 % [32].
We found that the use of hormone replacement therapy
or oral contraceptives was independently associated with a
higher serum 25(OH)D. An explanation for this could be
that estrogens stimulate the synthesis of vitamin D-binding
protein (DBP) [33]. One earlier study also found increased
levels of vitamin D metabolites and DBP in women using
oral contraceptives [34]. Increased levels of DBP have also
been found in pregnant women and in postmenopausal
women using hormone replacement therapy [35].
The association between low serum 25(OH)D and high
BMI found in the present study is supported by several
previous studies [36–38]. Vitamin D deficiency in obese
individuals may be caused by storage of 25(OH)D in the
adipose tissue. Other proposed mechanisms are high ex-
pression of the vitamin D receptor (VDR) in adipose tissue
and vitamin D possibly playing a role in the pathogenesis
of the metabolic syndrome. [5] We found lower levels of
serum 25(OH)D in smokers than in non-smokers. Earlier
studies have yielded conflicting results, showing lower,
unchanged, or higher levels of 25(OH)D in serum among
smokers [39–41].
Study subjects performing exercise regularly, at least
once a week, had higher serum concentrations of 25(OH)D
than the physically inactive during the summer period, but
not during the winter. Our interpretation of this result is
that physical activity during the summer is associated with
out-door activities.
Numerous studies have linked chronic illnesses with
hypovitaminosis D. To prove whether a poor vitamin D
status is the cause or the result of the illness is however a
challenge, since there are many possible confounding fac-
tors. The present study puts emphasis on the importance of
controlling for season in studies conducted at northern lati-
tudes. Many chronic illnesses are associated with a de-
creased physical function, less out-door activity and
consequently less UV-B exposure. Liver and bowel diseases
can in addition lead to malabsorption of vitamin D. Chronic
illness is also often associated with a poorer socioeconomic
status, lower educational level, and reduced economic re-
sources to spend on sun holidays, multivitamins, and vi-
tamin D-rich nutrients such as fish and shellfish.
Limitations of the present study were the lack of in-
formation regarding the dietary intake of vitamin D of the
participants. The absolute majority of the participants were
Caucasians, but more detailed information about skin type
or color was not obtained. In addition, blood and throm-
bocyte donors are selected populations and the thrombo-
cyte donors were mostly male. As a result, the study may
not be representative of the general Swedish population.
Conclusions
Vitamin D insufficiency is common in the Swedish healthy
adult population. We found that approximately 50 % of the
study population had serum concentrations of 25(OH)D
below 50 nmol/L during at least half of the year, and that
75 % had concentrations below 75 nmol/L during 75 % of
the year. Furthermore, the study indicates that it is possible
to extrapolate individual seasonal variations in 25-OHD
levels from a single serum sample. The serum 25(OH)D
concentration was strongly associated with exposure to UV
light but only weakly with intake of vitamin D supplements.
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